NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Of course the caveat is there could be more alive in the crossover group at five years (from randomization) than I can guess, because, there are 18 control patients that did not have their Progression event accounted for in the NYAS data, which leaves me even more blinded, (and they so far only count survival time from time of Progression event for the crossovers adding to my blindness)

Also remember, the crossovers did not receive Temodar after crossing over.